Arteris Inc
3 nominees · 2 ballot items.
Stockholders will vote to elect three Class II directors (Antonio J. Viana, Wayne C. Cantwell and Joachim Kunkel) and to ratify Deloitte & Touche LLP as the company's independent registered public accounting firm for the year ending December 31, 2026.
Follow how the vote landed and what changed on Arteris Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot2
- 1
Election of three Class II directors
ManagementBoard: FORVote to elect three Class II directors (Antonio J. Viana, Wayne C. Cantwell and Joachim Kunkel) to hold office until the 2029 annual meeting or until their successors are elected and qualified.
- 2
Ratification of appointment of independent registered public accounting firm and independent auditor (Deloitte & Touche LLP
ManagementBoard: FORVote to ratify the Audit Committee’s appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm and independent auditor for the year ending December 31, 2026.
Nominees on the ballot3
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | NEEDHAM INVESTMENT MANAGEMENT LLC | 6.8% | 3,125,000 | $51M |
| 2 | FRANKLIN RESOURCES INC | 3.8% | 1,762,475 | $29M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 3.0% | 1,366,677 | $22M |
| 4 | Samjo Management, LLC | 2.5% | 1,144,030 | $19M |
| 5 | BlackRock, Inc. | 2.4% | 1,115,939 | $18M |
| 6 | ACADIAN ASSET MANAGEMENT LLC | 2.0% | 933,521 | $15M |
| 7 | NEEDHAM INVESTMENT MANAGEMENT LLC | 1.8% | 827,500 | $14M |
| 8 | STATE STREET CORP | 1.8% | 816,859 | $13M |
| 9 | BlackRock, Inc. | 1.6% | 726,289 | $12M |
| 10 | Granahan Investment Management, LLC | 1.5% | 713,077 | $12M |
Other Technology sector meetings6
Upcoming shareholder meetings at Arteris Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Arteris Inc 2026 annual meeting?
- Arteris Inc (AIP) holds its 2026 annual shareholder meeting on Tuesday, June 2, 2026.
- What is the record date for the Arteris Inc 2026 meeting?
- The record date for the Arteris Inc 2026 meeting is Thursday, April 9, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Arteris Inc's 2026 meeting?
- The board is presenting 3 director nominees at the Arteris Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Arteris Inc 2026 meeting?
- Shareholders will vote on 2 proposals at the Arteris Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.